Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

watson laboratories, inc. - atenolol (unii: 50vv3vw0ti) (atenolol - unii:50vv3vw0ti) - tablet - hypertension atenolol tablets are indicated in the management of hypertension. they may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. angina pectoris due to coronary atherosclerosis atenolol tablets are indicated for the long-term management of patients with angina pectoris. acute myocardial infarction atenolol tablets are indicated in the management of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. treatment can be initiated as soon as the patient’s clinical condition allows. (see dosage and administration, contraindications, and warnings.) in general, there is no basis for treating patients like those who were excluded from the isis-1 trial (blood pressure less than 100 mm hg systolic, heart rate less than 50 bpm) or have other reasons to avoid beta blockade. as noted above, some subgroups (e.g., elderly patients with systolic blood pressure below 120 mm hg) seemed les

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

watson laboratories, inc. - atenolol (unii: 50vv3vw0ti) (atenolol - unii:50vv3vw0ti) - tablet - hypertension atenolol tablets are indicated in the management of hypertension. they may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. angina pectoris due to coronary atherosclerosis atenolol tablets are indicated for the long-term management of patients with angina pectoris. acute myocardial infarction atenolol tablets are indicated in the management of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. treatment can be initiated as soon as the patient’s clinical condition allows. (seedosage and administration , contraindications , andwarnings . ) in general, there is no basis for treating patients like those who were excluded from the isis-1 trial (blood pressure less than 100 mm hg systolic, heart rate less than 50 bpm) or have other reasons to avoid beta blockade. as noted above, some subgroups (e.g., elderly patients with systolic blood pressure below 120 mm hg) seemed

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - atenolol, quantity: 100 mg - tablet, film coated - excipient ingredients: magnesium carbonate hydrate; sodium starch glycollate type a; colloidal anhydrous silica; maize starch; sodium lauryl sulfate; magnesium stearate; purified water; hypromellose; macrogol 6000; titanium dioxide; purified talc - atenolol is indicated in the management of:,(i) all grades of hypertension, including hypertension of renal origin. (ii) frequent disabling angina without evidence of cardiac failure. (iii) cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction), (iv) myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - atenolol, quantity: 100 mg - tablet, film coated - excipient ingredients: magnesium carbonate hydrate; sodium starch glycollate type a; colloidal anhydrous silica; maize starch; sodium lauryl sulfate; magnesium stearate; purified water; hypromellose; macrogol 6000; titanium dioxide; purified talc - atenolol is indicated in the management of:,(i) all grades of hypertension, including hypertension of renal origin. (ii) frequent disabling angina without evidence of cardiac failure. (iii) cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction), (iv) myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)